REPL Stock Analysis: Buy, Sell, or Hold?

REPL - Replimune Group, Inc.

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
$9.94
-1.05 (-9.60%) β–Ό
5d: -13.38%
30d: +17.3%
90d: +108.72%
WAIT
LOW Confidence
Protect Your REPL Gains
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 06, 2026 22d

Get Alerted When REPL Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
⏸️ WAIT FOR STABILIZATION: REPL is down 13.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
See Forward Earnings Fair Value & Price Prediction β†’

In-depth Analysis How we analyze

Valuation Analysis: REPL is currently trading at $9.94, which is considered fair relative to its 30-day fair value range of $9.28 to $11.43.

Technical Outlook: Technically, REPL is in a strong downtrend. The price is currently testing key support at $9.79. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 9.6% recently.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $9.28 - $11.43
Company Quality Score 57/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 64.2%

Protect Your Profits

Holding REPL? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-9.6%)
  • NEUTRAL: Near Wall St target ($10.67)
  • WARNING: Recommendation downgraded due to -13.4% 5-day decline - wait for stabilization

Trading Range Analysis

30-Day Trading Range $9.28 - $11.43
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $9.79
Resistance Level $12.50
Current Trend Strong Downtrend
Technical data as of Jul 13, 2026

Fundamental Context

Forward P/E (Next Year Est.) -4.76
Wall Street Target $10.67 (+7.4%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 13, 2026 11:31 PM ET
Data refreshes hourly during market hours. Next update: 12:31 AM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Christopher Sarchi SELL 6500 shares 2026-04-02

Unlock Insider Activity

See real-time buying/selling by company executives for REPL.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ONC
BeiGene, Ltd.
STRONG BUY
24 analysts
$413 54 HOLD
INSM
Insmed Inc
STRONG BUY
21 analysts
$197 54 HOLD
BNTX
BioNTech SE
STRONG BUY
21 analysts
$122 55 HOLD
APLS
Apellis Pharmaceuticals …
BUY
22 analysts
$41 59 HOLD
VRDN
Viridian Therapeutics Inc
STRONG BUY
16 analysts
$36 61 BUY

Advanced REPL Option Strategies

Professional options setups generated by AI based on today's REPL price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for REPL

REPL Technical Chart REPL Price Prediction REPL Earnings Date REPL Investment Advisor REPL Fair Price Analyzer REPL Options Advisor REPL Options Chain REPL Options Analysis REPL Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals